Safety Study of Galantamine in Tic Disorders
Pilot Examination of Galantamine in the Management of Tic Disorders
Sponsor: Ortho-McNeil Neurologics, Inc.
Terminated
Unable to recruit subjects into the trial.
Other terminated trials from Ortho-McNeil Neurologics, Inc.
More terminations from Ortho-McNeil Neurologics, Inc.
This PHASE4 trial investigates Motor Tic Disorder and Tourette's Syndrome and is currently terminated or withdrawn. Ortho-McNeil Neurologics, Inc. leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Sep 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ortho-McNeil Neurologics, Inc.
- Parkinson's Disease and Movement Disorders Center
For direct contact, visit the study record on ClinicalTrials.gov .